研究紹介
学会発表・講義(国際)
- 2023年
- 2022年
国際学会 2022
Transplantation Science Symposium Asian Regional Meeting 2022
November 25-26, 2022 (Kyoto, Japan)
Takayuki Hirose: Mechanisms and Utility of IVIG in Kidney Transplantation.
Kiyohiko Hotta: Development of immunomonitoring system to predict chronic active antibody- mediatedrejection in kidney transplant recipients..
Naoya Iwahara, Kiyohiko Hotta, Takayuki Hirose, Nobuo Shinohara: Late Conversion to a CalcineurinInhibitor-Free Regimen with Everolimus After Renal Transplantation.
Naoya Iwahara, Kiyohiko Hotta, Takayuki Hirose, Nobuo Shinohara: Novel Mixed Lymphocyte Reaction Assay that Predicts Chronic Antibody Mediated Rejection in Kidney Transplant.
国際学会 2023
American Urological Association (AUA2023)
April 28-May 1, 2023 (Chicago, USA)
Shigeru Harada, Takashige Abe, Jun Furumido, Keita Takahashi, Masafumi Kon, Sachiyo Murai, Hiroshi Kikuchi, Haruka Miyata, Ryuji Matsumoto, Takahiro Osawa, Nobuo Shinohara: Mental workloads of surgeons in urology: A prospective observational study.
Takahiro Osawa, Miho Sato, Takashige Abe, Michitaka Honda, Madoka Higuchi, Shuhei Yamada, Jun Furumido, Hiroshi Kikuchi, Ryuji Matsumoto, Yasuyuki Sato, Yoshihiro Sasaki, Toru Harabayashi, Satoru Maruyama, Norikata Takada, Keita Minami, Hiroshi Tanaka, Ken Morita, Akira Kashiwagi, Sachiyo Murai, Yoichi M. Ito, Katsuhiko Ogasawara, Nobuo Shinohara: The body image scale (BIS) can identify symptoms related to body image after bladder cancer treatment: Validation of the Japanese version of the BIS.
American Transplant Congress (ATC2023)
June 3-7, 2023 (San Diego, USA)
Kiyohiko Hotta, Takahiro Osawa, Isao Yokota, Tasuku Inao, Tatsu Tanabe, Naoya Iwahara, Nobuo Shinohara: Longitudinal Mortality Risks and Renal Functional Outcomes in Living Kidney Donors.
Kiyohiko Hotta, Takayuki Hirose, Naoya Iwahara, Daiki Iwami, Nobuo Shinohara: Safety and Efficacy of Retroperitoneoscopic native nephrectomy in renal transplant recipients with autosomal dominant polycystic kidney disease.
Takayuki Hirose, Kiyohiko Hotta, Naoya Iwahara, Nobuo Shinohara: Preconditioning using rituximab reduces incidence of acute T-cell mediated rejection and prevents development of anti-HLA antibodies.
Takayuki Hirose, Daniel Firl, Ahmad Karadagi, Toshihide Tomosugi, Grace Lassiter, Ranjith Anand, David Haje, Jacob Layer, Viollete Paragas, Mike Curtis, Wenning Qin, Michelle Youd, Ivy Rosales, Eli Katz, Tatsuo Kawai: Genetically Modified Porcine Kidneys Expressing Human Transgenes Support > 2-year Survival in Pig to Cynomolgus Macaque Xenotransplantation.
Tatsuya Hoshi, Takayuki Hirose, Kiyohiko Hotta, Kanako Fuyama, Kazufumi Okada, Naoya Iwahara, Hiroki Chiba, Madoka Higuchi, Nobuo Shinohara: Successful kidney transplantation improves atrophic bladder capacity and function within 3 months after transplantation in patients with end-stage renal disease.
Yusuke Takada , Tatsu Tanabe , Hajime Sasaki , Keita Minami , Hiroshi Tanaka , Hiroshi Harada: Kidney donors older than 50 years have an increased risk for calcineurin inhibitor induced nephrotoxicity.
Congress of Asian Society of Transplantation
August 25-28, 2023 (Hong Kong)
Keisuke Maeda, Kiyohiko Hotta, Takayuki Hirose, Naoya Iwahara, Keita Kawashiro, Shigeru Harada, Yusuke Takada, Haruka Higuchi, Hajime Sasaki, Tatsu Tanabe, Ken Morita, Nobuo Shinohara: The impact of preoperative dialysis duration on renal allograft survival rate.
Takayuki Hirose, Kiyohiko Hotta, Naoya Iwahara, Nobuo Shinohara: Preconditioning using rituximab reduces incidence of acute T-cell mediated rejection and prevents development of anti-HLA antibodies.
The 2nd meeting of the Joint Symposium by the Korean Urological Oncology Society and the East-Asia Urological Oncology Society (EAUOS2023)
September 15-16, 2023 (Incheon, Korea )
Takahiro Osawa: Current role of Active Surveillance for Small Renal Mass: Benefits and risks.
European Society for Medical Oncology (ESMO2023)
October 20-24, 2023 (Madrid)
Takuya Moriguchi, Masahiro Sonoshita, Nobuo Shinohara: Developing novel therapeutics for bladder cancer leveraging Drosophila models .
ASCO-Genitourinary cancers symposium
February 16-18, 2024 (San Francisco, USA)
Takahiro Osawa, Go Kimura, Yasuhisa Fujii, Yosuke Uchitomi, Kazunori Honda, Ariko Otani, Miki Kondo, Tetsuya Wako, Yoshihide Mitsuda, Daisuke Kawai, Michiko Sugawara, Hiromi Kitano, Nobuo Shinohara: Cross-sectional study of patientsʼ (pts) and physiciansʼ needs and the financial toxicity of systemic treatment for metastatic renal cell carcinoma (mRCC) in Japan.
Advancements in Urology: An AUA/JUA Symposium 2023
March 6-9, 2024 (California, USA)
Hiroki Chiba: Urinary Incontinence, Voiding Dysfunction and Prolapse Management.